Roche’s Genentech debuts first consumer effort for diabetes and age-related eye disease drug
Genentech’s first campaign for eye drug Vabysmo is literally eye-opening. In the debut TV commercial, a woman opens an eye-shaped screen, stepping through into different beach, gardening and hiking scenarios. The campaign theme “Open Up Your World” mirrors her narration that the eye medication can improve eyesight and “open up” favorite activities for people with […]
Spherix Global Insights Announces Exhibition and Releases the Title of Their Abstract to be Presented at the 2022 ARVO Annual Meeting
Recent survey data reveals changes afoot in the neovascular (wet) age-related macular degeneration market EXTON, Pa., March 2, 2022 /PRNewswire/ — Spherix Global Insights, an independent market intelligence firm, recently collected feedback from 103 US ophthalmologists on the neovascular age-related macular degeneration (nAMD) treatment landscape. Insights from the RealTime Dynamix™ report revealed that market leader, […]
Roche’s Vabysmo to Offer ‘Fierce Competition’ to Regeneron’s Eylea, But a Long Market Battle Awaits: Spherix
Content area
